Please assess the completion status of the following clinical trial:

Trial Title: Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Surgically confirmed endometriosis~* Age between 15-40 y, and premenopausal~* Pelvic pain score ≥3 on a Visual Analog Scaleover the last month~Exclusion Criteria:~* Use of other concurrent hormone medications (such as birth control pills)~* Impaired liver function (ALT \> 2x normal) or liver disease (cirrhosis, hepatitis)~* Pregnancy~* Breast cancer~* Active thromboembolic disease~* Uncontrolled hypertension, history of cardiac valve disorder, history of fibrotic disorders

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: ACTIVE_COMPARATOR): Norethindrone acetate 5 mg po daily x 6 months
- Experimental (Type: EXPERIMENTAL): cabergoline 0.5 mg PO twice weekly x 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).